Top Leaderboard, Site wide
Truthdig: Drilling Beneath the Headlines
June 23, 2017 Disclaimer: Please read.

Statements and opinions expressed in articles are those of the authors, not Truthdig. Truthdig takes no responsibility for such statements or opinions.

Senate GOP Releases Obamacare Overhaul to Immediate Criticism From Both Sides of the Aisle

What’s Next for the Bill Cosby Sex-Assault Case?

Truthdig Bazaar more items

Ear to the Ground
Email this item Print this item

New Test Could Make Antidepressants Safer

Posted on Jan 13, 2014


Antidepressants are wildly popular in the United States, where one in 10 people take them. The problem is that they sometimes cause what’s called suicidal ideation—thoughts of suicide.

A new genetic test may help doctors identify those patients for whom it’s most likely to be a problem, and thus make prescriptions vastly safer.

The Verge:

A new test being developed by Sundance Diagnostics promises a different tactic. Scientists at the Max Planck Institute isolated 79 genetic markers correlated with an increased risk of antidepressant-induced suicide risk. Taken together, the latest tests show a 91 percent chance of identifying in advance whether antidepressants will trigger suicidal thoughts in a patient taking SSRI-based antidepressants. If the results hold, such a test would let doctors prescribe the drugs with much less fear of an unknown. “It is very important not to deprive patients of antidepressants because of this side effect,” says Andreas Menke, a lead researcher on the study, “but to identify patients at risk and provide these patients at risk with closer monitoring.”

It will take at least another year and a half to conduct the tests necessary for FDA approval, which will test out the markers in a much broader human population over a longer period of time. In the meantime, the lab-developed version may be trickling out to doctors over the next few months. And the test certainly has the potential to find a big market: 11 percent of Americans over the age of 12 takes some form of antidepressant, according to a 2011 study from the US Centers for Disease Control and Prevention, but there’s still no proven way to predict or guard against suicidal side effects. For the most part, it’s left to patients to self-monitor and self-report. A precautionary test could become standard practice whenever an antidepressant is prescribed. “This is something we’ve been looking for in the field for a long time,” says Sundance’s consulting doctor Peter Tolias.

Read more

—Posted by Peter Z. Scheer

Banner, End of Story, Desktop
Banner, End of Story, Mobile
Watch a selection of Wibbitz videos based on Truthdig stories:

Get a book from one of our contributors in the Truthdig Bazaar.

Related Entries

Get truth delivered to
your inbox every day.

New and Improved Comments

If you have trouble leaving a comment, review this help page. Still having problems? Let us know. If you find yourself moderated, take a moment to review our comment policy.

Join the conversation

Load Comments
Right Top, Site wide - Care2
Right Skyscraper, Site Wide
Right Internal Skyscraper, Site wide

Like Truthdig on Facebook